Derisking The Development Of Sensitive Injectables Aptar Derisking the development of sensitive injectables. in this webinar presented by aptar pharma, sebastien cordier, an industry leader in injectable drug delivery and packaging solutions, delivered a comprehensive review on extractables and leachables (e&l) for primary packaging, the manufacture of rubber components used in pharmaceutical. In an era where the integrity of sensitive injectables is paramount, aptar pharma is proud to announce an upcoming educational webinar titled “derisking the development of sensitive injectables with premiumcoat ®: our proven etfe film coated platform.”.
Aptar Pharma Hosts Webinar On Derisking The Development Of Sensitive Join aptar pharma’s webinar on june 6 entitled "derisking the development of sensitive injectables," presented by sebastien cordier. discover the essentials for regulatory filings and the. The use of highly sensitive vaccines technologies and increasing use of biologics strains the supply chain for etfe coated closure components worldwide. while one supplier currently provides the vast majority of coated components to the global pharmaceutical market, other options exist for facilitating new drug development projects and ensuring. In this edition of drug development & delivery, discover our premiumcoat® platform of etfe film coated solutions. claire raynal olive explains how these vial stoppers and pre filled syringe plungers protect sensitive drugs and help derisk product development to reach the market faster. download publication. author (s): c. raynal olive. Aptar pharma hosts webinar on derisking the development of sensitive injectables with premiumcoat® who is recognized with a 2024 leading women award by the world business council for.
Aptar Pharma Premiumcoatв Accelerating Derisking Injectable Drug In this edition of drug development & delivery, discover our premiumcoat® platform of etfe film coated solutions. claire raynal olive explains how these vial stoppers and pre filled syringe plungers protect sensitive drugs and help derisk product development to reach the market faster. download publication. author (s): c. raynal olive. Aptar pharma hosts webinar on derisking the development of sensitive injectables with premiumcoat® who is recognized with a 2024 leading women award by the world business council for. Join aptar pharma’s webinar on june 6 entitled "derisking the development of sensitive injectables," presented by sebastien cordier. discover the essentials for regulatory filings and the. Date 123: 6 june | 3:30pm london 4:30pm paris 10:30am new york.
Comments are closed.